Table 1.

Patient characteristics (N=90).

Treatment pathway	Tumor site	Treatment intent	Patients, n (%)
Capecitabine chemotherapy with or without oxaliplatin chemotherapy	Colorectal	Adjuvant	11 (12)
Abiraterone and enzalutamide	Prostate	Palliative	10 (11)
Breast radiotherapy	Breast	Adjuvant	10 (11)
Head and neck radiotherapy	Head and neck	Radical	10 (11)
Single-agent immunotherapy (nivolumab or pembrolizumab)	Melanoma	Palliative and adjuvant	10 (11)
Prostate radiotherapy	Prostate	Radical	10 (11)
Pazopanib	Renal	Palliative	10 (11)
Imatinib	Gastrointestinal stromal tumor	Palliative and adjuvant	8 (9)
Stereotactic ablative radiotherapy	Lung	Radical	6 (7)
Docetaxel chemotherapy	Prostate	Palliative	5 (6)